Project Grant R01EB039053
- The National Institute of Biomedical Imaging and Bioengineering awarded The Leland Stanford Junior University $217,500 on April 10, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop portable resonance gradient coils for faster MRI with simplified calibration and real-time image reconstruction. The project addresses limitations in MRI encoding speed that constrain exam duration, scheduling availability, and...
- The National Cancer Institute, within the Department of Health and Human Services, awarded The Leland Stanford Junior University $606,756 on August 1, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394). The award funds development and validation of foundation model-augmented artificial intelligence tools to enable accurate and efficient image guidance in upright proton therapy for lung cancer treatment. The research will create a vision-language framework for...
- The National Institute of Biomedical Imaging and Bioengineering awarded Sloan-Kettering Institute for Cancer Research $636,110 on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop motion-tolerant pediatric MRI technology that reduces anesthesia dependence in tumor imaging. The funded research develops deep learning reconstruction techniques combined with radial k-space acquisition to compensate for...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded The Leland Stanford Junior University $731,500 on September 1, 2026, under the Trans-NIH Research Support program (CFDA 93.310) to develop physics-informed machine learning systems for medical image analysis. The project will build a generative simulation environment that models dynamic human anatomy and physiology to produce realistic synthetic imaging data such as radiographs and CT scans...
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of Texas at Austin $618,695 on April 20, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop an adaptive and reconfigurable robot-assisted Single Photon Emission Computed Tomography (SPECT) imaging system. The project focuses on designing, integrating, and validating subsystems for a novel SPECT platform that personalizes imaging...
- The National Institute of Biomedical Imaging and Bioengineering awarded $161,000 to the University of California, Davis on May 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop an affordable dynamic total-body positron emission tomography (TB PET) imaging system using sparse detector architectures. The research addresses cost barriers to TB PET adoption by reducing scintillator material and readout electronics...
- The National Institute of Biomedical Imaging and Bioengineering awarded The Regents of the University of California, operating Lawrence Berkeley National Laboratory, $312,165 on June 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop Time-of-Flight Multi-Photon Emission Tomography (TOF-MPET) for direct imaging of therapeutic radionuclides in cancer treatment. The project addresses limitations in current imaging...
- The National Institute of Biomedical Imaging and Bioengineering awarded The Johns Hopkins University $507,987 on April 23, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop scintillator-based photon counting detectors for X-ray computed tomography systems. The research addresses cost and image quality barriers in photon counting detector CT technology by replacing semiconductor-based detectors with...
- The National Cancer Institute awarded the Regents of the University of California, San Francisco $700,838 on April 1, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop and optimize magnetic resonance multi-tasking abdominal imaging (MT-AI2) and advanced non-coplanar planning methods for functional avoidance stereotactic body radiation therapy (FA-SBRT) in primary and secondary liver tumors. The project aims to reduce radiation-induced liver disease (RILD)...
- The National Institute of Neurological Disorders and Stroke awarded The Leland Stanford Junior University $499,516 on February 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (NINDS, CFDA 93.853) to develop a novel imaging strategy for optimizing brain tumor immunotherapy. The recipient will develop a first-in-class small molecule positron emission tomography (PET) probe capable of crossing the blood-brain barrier and binding to perforin, a...
The National Institute of Biomedical Imaging and Bioengineering awarded The Leland Stanford Junior University $2,719,451 on August 18, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop next-generation nonstop gated cone-beam computed tomography (NGCBCT) for respiratory gating in stereotactic body radiation therapy for early-stage lung cancer. The project addresses imaging delays and radiation dose inefficiencies in current free-breathing gated CBCT (GCBCT) procedures used for pretreatment verification in lung SBRT. Standard GCBCT requires lengthy continuous gantry rotation with the X-ray beam active throughout, extending patient imaging time and discomfort while increasing imaging dose compared to standard 3D CBCT. Lung SBRT patients typically undergo multiple fractions with one to two GCBCT scans per fraction; patients with multiple tumors requiring multi-isocenters face doubled or tripled scan counts, further extending imaging time and limiting clinical throughput. NGCBCT will enable continuous gantry rotation (one minute per scan) with the X-ray beam activated only during the predefined gating window of the respiratory cycle, thereby reducing imaging time and dose while maintaining the motion-artifact reduction and tumor visualization benefits of gated imaging. Place of performance is New York, New York. The period of performance extends from August 18, 2026, through July 31, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $2.7m | 8/18/26 |